biospecimen__admin__batch_number	100.78.0
biospecimen__admin__bcr	Nationwide Children's Hospital
biospecimen__admin__day_of_dcc_upload	1
biospecimen__admin__disease_code	LIHC
biospecimen__admin__file_uuid	CF154907-B5F4-423D-B670-DBA6931E1383
biospecimen__admin__month_of_dcc_upload	7
biospecimen__admin__year_of_dcc_upload	2016
biospecimen__bio__bcr_analyte_barcode	TCGA-BC-A10Q-01A-11R
biospecimen__bio__bcr_portion_barcode	TCGA-BC-A10Q-01A-11
biospecimen__bio__bcr_sample_barcode	TCGA-BC-A10Q-01A
biospecimen__bio__biospecimen_barcode_bottom	0099015866
biospecimen__bio__day_of_creation	20
biospecimen__bio__day_of_shipment	01
biospecimen__bio__days_to_index	0
biospecimen__bio__gel_image_file	https://sharedoc.nchri.org/tcga-bcr/default.aspx
biospecimen__bio__is_derived_from_ffpe	NO
biospecimen__bio__month_of_creation	01
biospecimen__bio__month_of_shipment	03
biospecimen__bio__pathology_report_file_name	TCGA-BC-A10Q.10117C34-85C2-49DE-B2AD-F8D0D4570DA9.pdf
biospecimen__bio__plate_column	1
biospecimen__bio__plate_id	A131
biospecimen__bio__plate_row	B
biospecimen__bio__portion_sequence	1
biospecimen__bio__quantity	4.54
biospecimen__bio__subportion_sequence	1
biospecimen__bio__vial_number	A
biospecimen__bio__volume	26.70
biospecimen__bio__year_of_creation	2011
biospecimen__bio__year_of_shipment	2011
biospecimen__shared__bcr_patient_barcode	TCGA-BC-A10Q
biospecimen__shared__patient_id	A10Q
clinical__ablation__ablation_performed_indicator	NO
clinical__ablation__bcr_ablation_barcode	TCGA-BC-A10Q-A13754
clinical__ablation__bcr_ablation_uuid	38B7049A-E74F-4548-9AAE-D604D4C697BD
clinical__ablation__days_to_embolization_performed	217
clinical__ablation__embolization_performed_indicator	YES
clinical__ablation__embolization_therapy_drug_name	Other
clinical__ablation__embolization_therapy_drug_name_other	Doxorubicon and Mitomycin C
clinical__ablation__embolization_type	Chemoembolization
clinical__ablation__embolizing_agent_utilized	Other, specify
clinical__ablation__embolizing_agent_utilized_other	PVA particles
clinical__admin__day_of_dcc_upload	22
clinical__admin__file_uuid	17AE4D15-47B4-42FA-BAFB-9BAB78965787
clinical__admin__month_of_dcc_upload	12
clinical__admin__withdrawn	false
clinical__chol_lihc_shared__albumin_result_lower_limit	3.5
clinical__chol_lihc_shared__albumin_result_specified_value	4.1
clinical__chol_lihc_shared__albumin_result_upper_limit	5.0
clinical__chol_lihc_shared__bilirubin_upper_limit	.5
clinical__chol_lihc_shared__creatinine_lower_level	0.7
clinical__chol_lihc_shared__creatinine_upper_limit	1.1
clinical__chol_lihc_shared__creatinine_value_in_mg_dl	0.6
clinical__chol_lihc_shared__hist_hepato_carc_fact	No History of Primary Risk Factors
clinical__chol_lihc_shared__platelet_result_lower_limit	150
clinical__chol_lihc_shared__platelet_result_upper_limit	440
clinical__chol_lihc_shared__prothrombin_time_result_value	0.9
clinical__chol_lihc_shared__specimen_collection_method_name	Extended Lobectomy
clinical__chol_lihc_shared__vascular_tumor_cell_type	None
clinical__clin_shared__age_at_initial_pathologic_diagnosis	72
clinical__clin_shared__bcr_followup_barcode	TCGA-BC-A10Q-F9852
clinical__clin_shared__bcr_followup_uuid	40B443A9-BAED-4DA5-A36C-F6A5DDE121BD
clinical__clin_shared__cancer_first_degree_relative	1
clinical__clin_shared__day_of_form_completion	1
clinical__clin_shared__days_to_initial_pathologic_diagnosis	0
clinical__clin_shared__informed_consent_verified	YES
clinical__clin_shared__month_of_form_completion	3
clinical__clin_shared__person_neoplasm_cancer_status	WITH TUMOR
clinical__clin_shared__platelet_result_count	287000
clinical__clin_shared__postoperative_rx_tx	YES
clinical__clin_shared__radiation_therapy	NO
clinical__clin_shared__regimen_indication	ADJUVANT
clinical__clin_shared__relative_family_cancer_history	YES
clinical__clin_shared__residual_tumor	R1
clinical__clin_shared__tissue_prospective_collection_indicator	NO
clinical__clin_shared__tissue_retrospective_collection_indicator	YES
clinical__clin_shared__tumor_tissue_site	Liver
clinical__clin_shared__year_of_form_completion	2011
clinical__clin_shared__year_of_initial_pathologic_diagnosis	1998
clinical__lihc_nte__new_tumor_event_ablation_embo_tx	No
clinical__nte__additional_pharmaceutical_therapy	YES
clinical__nte__additional_radiation_therapy	NO
clinical__nte__days_to_new_tumor_event_after_initial_treatment	340
clinical__nte__new_neoplasm_event_type	Intrahepatic Recurrence
clinical__nte__new_tumor_event_additional_surgery_procedure	NO
clinical__nte__new_tumor_event_after_initial_treatment	YES
clinical__rx__bcr_drug_barcode	TCGA-BC-A10Q-D9855
clinical__rx__bcr_drug_uuid	A0F6AA78-BFC6-40A0-9127-D0F7F9AA42CF
clinical__rx__days_to_drug_therapy_end	217
clinical__rx__days_to_drug_therapy_start	359
clinical__rx__drug_name	adriamycin
clinical__rx__prescribed_dose_units	mg
clinical__rx__regimen_number	1
clinical__rx__therapy_ongoing	NO
clinical__rx__therapy_type	Other, specify in notes
clinical__rx__therapy_type_notes	chemoembolization
clinical__rx__total_dose_units	mg
clinical__shared__histological_type	Hepatocellular Carcinoma
clinical__shared__history_of_neoadjuvant_treatment	No
clinical__shared__other_dx	No
clinical__shared_stage__pathologic_m	MX
clinical__shared_stage__pathologic_n	NX
clinical__shared_stage__pathologic_t	T2
clinical__shared_stage__system_version	5th
gdc__access	open
gdc__acl	open
gdc__aliquots__aliquot_id	19c97e3d-f5af-4301-92f4-be8ac9e27427
gdc__aliquots__concentration	0.17
gdc__aliquots__source_center	23
gdc__aliquots__submitter_id	TCGA-BC-A10Q-01A-11R-A131-07
gdc__aliquots__updated_datetime	2018-09-06T14:13:07.098771-05:00
gdc__analysis__analysis_id	f4de59af-6672-437e-9341-78f8b4cde489,66fc5de6-56a6-4ffe-aa63-492c83309ec1,a83f9e55-b54a-4d95-ad99-fe11b5ed9291
gdc__analysis__workflow_link	https://github.com/NCI-GDC/htseq-cwl
gdc__analysis__workflow_type	HTSeq - Counts,HTSeq - FPKM,HTSeq - FPKM-UQ
gdc__analysis__workflow_version	v1
gdc__analytes__a260_a280_ratio	1.86
gdc__analytes__analyte_id	51819a9b-07b9-45f6-8b86-e9c415c249e1
gdc__analytes__analyte_type	RNA
gdc__analytes__analyte_type_id	R
gdc__analytes__spectrophotometer_method	UV Spec
gdc__case_id	dfa15fbe-bb14-40ce-afc6-70694112e3e2
gdc__center__center_id	ee7a85b3-8177-5d60-a10c-51180eb9009c
gdc__center__center_type	CGCC
gdc__center__code	07
gdc__center__name	University of North Carolina
gdc__center__namespace	unc.edu
gdc__center__short_name	UNC
gdc__created_datetime	2016-05-29T11:10:22.218332-05:00,2016-05-29T11:10:22.688290-05:00,2016-05-29T11:10:22.472981-05:00
gdc__data_category	Transcriptome Profiling
gdc__data_format	TXT
gdc__data_type	Gene Expression Quantification
gdc__demographic__demographic_id	2f81e314-1ffd-5b24-b4ba-06aaa9680e6b
gdc__demographic__ethnicity	not hispanic or latino
gdc__demographic__gender	female
gdc__demographic__race	white
gdc__demographic__year_of_birth	1926
gdc__demographic__year_of_death	2001
gdc__diagnoses__age_at_diagnosis	26400
gdc__diagnoses__classification_of_tumor	not reported
gdc__diagnoses__days_to_birth	-26400.0
gdc__diagnoses__days_to_death	1135.0
gdc__diagnoses__diagnosis_id	c896279a-640a-57f8-91c5-4d1b674cdcca
gdc__diagnoses__last_known_disease_status	not reported
gdc__diagnoses__morphology	8170/3
gdc__diagnoses__primary_diagnosis	Hepatocellular carcinoma NOS
gdc__diagnoses__prior_malignancy	not reported
gdc__diagnoses__progression_or_recurrence	not reported
gdc__diagnoses__site_of_resection_or_biopsy	Liver
gdc__diagnoses__tissue_or_organ_of_origin	Liver
gdc__diagnoses__tumor_grade	not reported
gdc__diagnoses__tumor_stage	not reported
gdc__diagnoses__vital_status	dead
gdc__disease_type	Adenomas and Adenocarcinomas
gdc__experimental_strategy	RNA-Seq
gdc__exposures__exposure_id	41801e4c-8d70-5266-82ae-382fc1dd4a20
gdc__file_id	3cb10e8d-9103-4f92-8166-75f6e664d79b,2cca55e5-5f9e-4d78-a738-e0f2d0ce5b49,9337e7a7-be11-47a2-b652-aa1ce28494f1
gdc__file_name	e621bfc8-6557-450e-8e4a-3f754294cb20.htseq.counts.gz,e621bfc8-6557-450e-8e4a-3f754294cb20.FPKM.txt.gz,e621bfc8-6557-450e-8e4a-3f754294cb20.FPKM-UQ.txt.gz
gdc__file_size	247790,493840,495059
gdc__input_files__data_category	Raw Sequencing Data
gdc__input_files__data_format	BAM
gdc__input_files__data_type	Aligned Reads
gdc__input_files__experimental_strategy	RNA-Seq
gdc__input_files__platform	Illumina
gdc__md5sum	2b9390291ac03648fe0e46243e8810a8,1174a75e1ae4a66b928ff59e2f1b5426,75587f39a70d56176bc46efe8e7fe233
gdc__portions__is_ffpe	false
gdc__portions__portion_id	f2ae8e36-b434-4d24-af65-d24aee902b2f
gdc__portions__portion_number	11
gdc__portions__weight	30.0
gdc__primary_site	Liver and intrahepatic bile ducts
gdc__program__dbgap_accession_number	phs000178
gdc__program__name	TCGA
gdc__program__program_id	b80aa962-9650-5110-b3eb-bd087da808db
gdc__project__disease_type	Liver Hepatocellular Carcinoma
gdc__project__primary_site	Liver
gdc__project__project_id	TCGA-LIHC
gdc__project__releasable	false
gdc__project__released	true
gdc__samples__days_to_collection	4437
gdc__samples__initial_weight	340.0
gdc__samples__oct_embedded	false
gdc__samples__pathology_report_uuid	10117C34-85C2-49DE-B2AD-F8D0D4570DA9
gdc__samples__sample_id	bf225dc1-4309-4304-849e-cbcc23c8442c
gdc__samples__sample_type	Primary Tumor
gdc__samples__sample_type_id	01
gdc__slides__percent_lymphocyte_infiltration	0.0
gdc__slides__percent_monocyte_infiltration	0.0
gdc__slides__percent_necrosis	0.0
gdc__slides__percent_neutrophil_infiltration	0.0
gdc__slides__percent_normal_cells	0.0
gdc__slides__percent_stromal_cells	10.0
gdc__slides__percent_tumor_cells	90.0
gdc__slides__percent_tumor_nuclei	80.0
gdc__slides__section_location	TOP
gdc__slides__slide_id	bb6e455c-3aea-4ffb-9615-2fd9f879832f
gdc__submitter_id	e621bfc8-6557-450e-8e4a-3f754294cb20_count,e621bfc8-6557-450e-8e4a-3f754294cb20_fpkm,e621bfc8-6557-450e-8e4a-3f754294cb20_uqfpkm
gdc__tissue_source_site__bcr_id	NCH
gdc__tissue_source_site__code	BC
gdc__tissue_source_site__name	UNC
gdc__tissue_source_site__tissue_source_site_id	735fda57-1a46-5afd-a1c0-99af9115c0af
gdc__treatments__treatment_id	c6950321-e76b-5549-abc5-e7154dde561e
gdc__type	gene_expression
gdc__updated_datetime	2018-09-08T13:43:34.032262+00:00
manually_curated__data_format	BED
manually_curated__download_date	2018-11-06T08:05:27.726+01:00
manually_curated__exp_data_bed_url	ftp://bioinformatics.iasi.cnr.it/opengdc/bed/tcga/tcga-lihc/gene_expression_quantification/19c97e3d-f5af-4301-92f4-be8ac9e27427-geq.bed
manually_curated__exp_metadata_url	ftp://bioinformatics.iasi.cnr.it/opengdc/bed/tcga/tcga-lihc/gene_expression_quantification/19c97e3d-f5af-4301-92f4-be8ac9e27427-geq.bed.meta
manually_curated__genome_built	GRCh38
manually_curated__local_file_size	5060887
manually_curated__local_md5	d8f4d30dbba2545833af30a597238722
manually_curated__opengdc_download_date	2018-10-15T16:30:03.000018+02:00
manually_curated__opengdc_file_md5	6bcc4e1bef5ed4b0333961f499fdcd60
manually_curated__opengdc_file_size	1651889
manually_curated__opengdc_id	19c97e3d-f5af-4301-92f4-be8ac9e27427-geq
manually_curated__origin_file_size	5060887
manually_curated__origin_last_modified_date	Mon Oct 15 16:38:00 CEST 2018
manually_curated__origin_md5	d8f4d30dbba2545833af30a597238722
manually_curated__tissue_status	tumoral
num	60483
